CN105223182A - A kind of method detecting doped chemical drugs in Chinese patent drug - Google Patents
A kind of method detecting doped chemical drugs in Chinese patent drug Download PDFInfo
- Publication number
- CN105223182A CN105223182A CN201510551339.5A CN201510551339A CN105223182A CN 105223182 A CN105223182 A CN 105223182A CN 201510551339 A CN201510551339 A CN 201510551339A CN 105223182 A CN105223182 A CN 105223182A
- Authority
- CN
- China
- Prior art keywords
- solution
- chinese patent
- tested
- chemicals
- thin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 94
- 229940079593 drug Drugs 0.000 title claims abstract description 67
- 239000000126 substance Substances 0.000 title claims abstract description 65
- 238000000034 method Methods 0.000 title claims abstract description 46
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 83
- 239000000243 solution Substances 0.000 claims abstract description 49
- 238000001514 detection method Methods 0.000 claims abstract description 43
- 235000011187 glycerol Nutrition 0.000 claims abstract description 31
- 238000001237 Raman spectrum Methods 0.000 claims abstract description 27
- 239000002904 solvent Substances 0.000 claims abstract description 23
- 238000001069 Raman spectroscopy Methods 0.000 claims abstract description 22
- 239000012086 standard solution Substances 0.000 claims abstract description 18
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 claims abstract description 17
- 239000003623 enhancer Substances 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229910052751 metal Inorganic materials 0.000 claims abstract description 12
- 239000002184 metal Substances 0.000 claims abstract description 12
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 9
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 238000004809 thin layer chromatography Methods 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 239000000047 product Substances 0.000 claims description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 238000000479 surface-enhanced Raman spectrum Methods 0.000 claims description 15
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 10
- 230000010354 integration Effects 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 230000005284 excitation Effects 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 claims description 2
- 239000012488 sample solution Substances 0.000 claims description 2
- 239000000741 silica gel Substances 0.000 claims description 2
- 229910002027 silica gel Inorganic materials 0.000 claims description 2
- 239000002082 metal nanoparticle Substances 0.000 abstract description 18
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 238000007689 inspection Methods 0.000 abstract 1
- 239000000084 colloidal system Substances 0.000 description 13
- 239000010410 layer Substances 0.000 description 12
- FZAQMSARZVYAAV-UHFFFAOYSA-N propane-1,2,3-triol silver Chemical compound [Ag].OCC(O)CO FZAQMSARZVYAAV-UHFFFAOYSA-N 0.000 description 10
- 238000010586 diagram Methods 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 208000006673 asthma Diseases 0.000 description 5
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 230000003595 spectral effect Effects 0.000 description 5
- JTUQXGZRVLWBCR-UHFFFAOYSA-N 1-[1-[2-(phenylmethyl)phenoxy]propan-2-yl]piperidine Chemical compound C1CCCCN1C(C)COC1=CC=CC=C1CC1=CC=CC=C1 JTUQXGZRVLWBCR-UHFFFAOYSA-N 0.000 description 4
- 229960001871 benproperine Drugs 0.000 description 4
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 3
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 3
- 238000009499 grossing Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000007781 pre-processing Methods 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
本发明提供了一种检测中成药中掺杂化学药品的方法,采用表面增强拉曼光谱和薄层色谱联用的方法进行检测,根据薄层斑点的比移值以及动态表面增强拉曼光谱来判定掺杂化学药品的成分,包括标准品溶液和待检药品溶液的制备、薄板层析、采集拉曼光谱三个步骤。在第三个步骤中,表面增强剂采用以甘油为溶剂的纳米金属溶胶,相对于现有技术选择水作为溶剂,甘油的粘度大,挥发性小,当其和金属纳米粒子混匀后,可以更长时间包裹在金属纳米粒子的外围,减少金属纳米粒子和外界接触而被氧化失效的机会,降低了金属纳米粒子的削减速度,进而提高了拉曼信号的稳定性和检测灵敏度,实现对低含量掺伪中成药更好的现场快检。
The invention provides a method for detecting doped chemicals in Chinese patent medicines, which adopts the combined method of surface-enhanced Raman spectroscopy and thin-layer chromatography for detection, and performs detection according to the ratio shift value of thin-layer spots and dynamic surface-enhanced Raman spectroscopy. Determine the composition of adulterated chemicals, including three steps: preparation of standard solution and drug solution to be tested, thin plate chromatography, and collection of Raman spectra. In the third step, the surface enhancer uses nano-metal sol with glycerin as the solvent. Compared with the prior art, water is selected as the solvent. Glycerin has high viscosity and low volatility. When it is mixed with metal nanoparticles, it can Wrapped around the metal nanoparticles for a longer period of time, reducing the chance of metal nanoparticles being oxidized and ineffective due to contact with the outside world, reducing the cutting speed of metal nanoparticles, thereby improving the stability and detection sensitivity of Raman signals, and achieving low Better on-site rapid inspection of adulterated Chinese patent medicines.
Description
技术领域technical field
本发明属于药品检测领域,具体涉及一种采用以甘油溶液为溶剂的金属纳米溶胶及其表面增强拉曼光谱检测方法进行中成药中掺杂化学药品的检测方法。The invention belongs to the field of drug detection, and in particular relates to a method for detecting doped chemicals in Chinese patent medicines by using a metal nano-sol with a glycerol solution as a solvent and a surface-enhanced Raman spectrum detection method thereof.
背景技术Background technique
中成药中掺杂化学药品的现象由来已久,且有愈演愈烈之势。由于掺入的化学药品的种类、数量、毒性等信息不为人所知,该药物的安全性根本无法保证,严重危害人民健康,且扰乱了药品市场的正当有序竞争,最终将影响到中药产业的可持续发展。The phenomenon of doping chemicals in Chinese patent medicines has a long history and is becoming more and more serious. Since the type, quantity, toxicity and other information of the chemical drugs mixed in are not known, the safety of the drug cannot be guaranteed at all, seriously endangering people's health, and disrupting the legitimate and orderly competition in the drug market, which will eventually affect the traditional Chinese medicine industry of sustainable development.
表面增强拉曼光谱法是近年来新兴的一种快速检测技术,具有灵敏度高、特征性强、检测时间短等优点。目前其与薄层色谱法联用的技术已应用于一些复杂体系的分离和检测,如水环境中的污染物,生物尿样中的代谢产物,中成药中违法添加的化学药物等。Surface-enhanced Raman spectroscopy is an emerging rapid detection technology in recent years, which has the advantages of high sensitivity, strong characteristics, and short detection time. At present, its technology combined with thin-layer chromatography has been applied to the separation and detection of some complex systems, such as pollutants in the water environment, metabolites in biological urine samples, and chemical drugs illegally added to Chinese patent medicines.
一般情况下,大多不法药厂为了使中成药快速达到明显的治疗效果,常常向其中违法添加化学药物且含量较高(大于1%)。这些中成药通常通过简单地萃取分离即能检测得到违法添加药物的较强的表面增强拉曼光谱,因此很容易通过便携式拉曼光谱仪对其进行快速检测,从而判定其是否掺假。Generally speaking, in order to make Chinese patent medicines quickly achieve obvious therapeutic effects, most illegal pharmaceutical factories often illegally add chemical drugs to them with high content (greater than 1%). These Chinese patent medicines can usually be detected through simple extraction and separation to obtain strong surface-enhanced Raman spectra of illegally added drugs, so it is easy to quickly detect them with a portable Raman spectrometer to determine whether they are adulterated.
但是随着掺伪技术不断提高,一些厂家通过降低掺假化药含量和增加掺假化药种类试图规避药监部门的检测。现有技术中常采用以水为溶剂的金属纳米溶胶作为表面增强剂,但将该表面增强剂滴加在薄板上时,其中的水分会快速挥发,导致其所包裹的金属粒子失去保护层而迅速被氧化,致使薄层板上检测待测物的表面增强拉曼散射(SERS)信号只能维持十几秒,难以得到持久的SERS信号,不利于实际检测。如,当掺杂化学药品的含量低于1%时,采用以水为溶剂的金属纳米溶胶作为表面增强剂,只能采集少数几个动态拉曼光谱,测试误差很大,结果难以令人信服,甚至无法实现检测。因此,直接用之前的表面增强拉曼光谱法时常难以检测到掺假药物。However, with the continuous improvement of adulteration technology, some manufacturers try to evade the detection of drug supervision departments by reducing the content of adulterated chemicals and increasing the types of adulterated chemicals. In the prior art, metal nano-sols with water as a solvent are often used as surface enhancers, but when the surface enhancer is dropped on a thin plate, the water in it will evaporate quickly, causing the metal particles wrapped in it to lose their protective layer and quickly lose their protective layer. It is oxidized, so that the surface-enhanced Raman scattering (SERS) signal for detecting the analyte on the thin-layer plate can only last for more than ten seconds, and it is difficult to obtain a lasting SERS signal, which is not conducive to actual detection. For example, when the content of doping chemicals is less than 1%, using metal nano-sol with water as the solvent as the surface enhancer can only collect a few dynamic Raman spectra, the test error is large, and the results are not convincing , even detection is not possible. Therefore, it is often difficult to detect adulterated drugs directly with the previous surface-enhanced Raman spectroscopy.
发明内容Contents of the invention
本发明是为解决上述问题而进行的,采用表面增强拉曼光谱与薄层色谱法联用的技术检测中成药中掺杂化学药品,将以甘油溶液为溶剂的纳米金属溶胶取代常用的以水为溶剂的纳米金属溶胶,进一步提高SERS信号的灵敏度和稳定性。采用了如下技术方案:The present invention is carried out in order to solve the above-mentioned problems. It adopts the technology of combining surface-enhanced Raman spectroscopy and thin-layer chromatography to detect doping chemicals in Chinese patent medicines, and replaces the commonly used nano-metal sol with glycerol solution as a solvent. The nano-metal sol as the solvent further improves the sensitivity and stability of the SERS signal. Adopted the following technical solutions:
本发明提供了一种检测中成药中掺杂化学药品的方法,采用表面增强拉曼光谱和薄层色谱联用的方法进行检测,根据薄层斑点的比移值以及动态表面增强拉曼光谱来判定所掺杂化学药品的成分,包括以下步骤:The invention provides a method for detecting doped chemicals in Chinese patent medicines, which uses surface-enhanced Raman spectroscopy and thin-layer chromatography for detection, according to the ratio shift value of thin-layer spots and dynamic surface-enhanced Raman spectroscopy. Determining the composition of adulterated chemicals includes the following steps:
步骤一,标准品溶液和待检药品溶液的制备:将一定量的标准品经溶剂溶解后,采用超声处理10~30min后,得到一定浓度的标准品溶液;待测药品依次进行研成粉末、溶剂溶解、超声处理10~30min后,离心取上清液,得到待检药品溶液。所采用的溶剂为甲醇、乙醇以及水中的任意一种。但在后续步骤中,相对于水和乙醇,甲醇溶解性最好,最易挥干,使得斑点扩散最小,所以优选甲醇。Step 1, preparation of standard solution and drug solution to be tested: After a certain amount of standard product is dissolved in a solvent, and ultrasonically treated for 10-30 minutes, a standard solution of a certain concentration is obtained; the drug to be tested is ground into powder, After dissolving in the solvent and ultrasonic treatment for 10-30 minutes, centrifuge to take the supernatant to obtain the drug solution to be tested. The solvent used is any one of methanol, ethanol and water. However, in the subsequent steps, compared with water and ethanol, methanol has the best solubility and is the easiest to evaporate to dryness, so that the spot spread is the smallest, so methanol is preferred.
步骤二,层析:将步骤一得到的标准品溶液以及待检药品溶液分别滴加于薄层板上,展开晾干后,采用光学方法对标准品以及待检药品中与标准品比移值相等的点进行定位,定位位置记为待检位点;Step 2, chromatography: drop the standard solution and the drug solution to be tested respectively on the thin-layer plate obtained in step 1, after unfolding and drying, use an optical method to compare the ratio shift value of the standard product and the drug to be tested with the standard product The equal points are positioned, and the positioned position is recorded as the point to be tested;
步骤三,采集拉曼光谱:将表面增强剂滴加于步骤二的待检位点处,采用便携式拉曼光谱仪对所述待检位点进行动态检测60s~240s,分别得到标准品以及待检药品的动态表面增强拉曼光谱图。该拉曼光谱仪的功率为150mW~300mW,积分时间为5s~10s。Step 3, collect Raman spectrum: add the surface enhancer dropwise to the site to be tested in step 2, and use a portable Raman spectrometer to dynamically detect the site to be tested for 60s to 240s, and obtain the standard product and the site to be tested respectively Dynamic surface-enhanced Raman spectra of pharmaceuticals. The power of the Raman spectrometer is 150mW-300mW, and the integration time is 5s-10s.
进一步的,本发明所提供的检测中成药中掺杂化学药品的方法,还具有这样的特征:所采用的表面增强剂为以甘油溶液为溶剂的纳米金属溶胶,纳米金属溶胶优选纳米银溶胶,甘油溶液和纳米银溶胶溶液的体积比为1:1~3,优选1:1(以下简称甘油银胶溶液)。Further, the method for detecting doped chemicals in Chinese patent medicines provided by the present invention also has the following characteristics: the surface enhancer used is nano-metal sol with glycerin solution as the solvent, and the nano-metal sol is preferably nano-silver sol, The volume ratio of the glycerol solution to the nano-silver sol solution is 1:1-3, preferably 1:1 (hereinafter referred to as the glycerin-silver colloid solution).
进一步的,本发明所提供的检测中成药中掺杂化学药品的方法,还具有这样的特征:上述甘油溶液中甘油的体积分数为10%~70%,优选30%~70%,最优选50%。Further, the method for detecting adulterated chemicals in Chinese patent medicines provided by the present invention also has the following characteristics: the volume fraction of glycerol in the glycerol solution is 10% to 70%, preferably 30% to 70%, most preferably 50% %.
进一步的,本发明所提供的检测中成药中掺杂化学药品的方法,还具有这样的特征:步骤二中所采用的薄层板为硅胶薄层板;进行薄板层析时,待检样品溶液和标准品溶液的滴加量均为1μL;层析完毕后,采用波长为254nm紫外光进行斑点定位。Further, the method for detecting doped chemicals in Chinese patent medicines provided by the present invention also has the following characteristics: the thin-layer plate used in step 2 is a silica gel thin-layer plate; when performing thin-plate chromatography, the sample solution to be tested The dropping volumes of the standard solution and the standard solution were both 1 μL; after the chromatography was completed, the spots were positioned using ultraviolet light with a wavelength of 254 nm.
进一步的,本发明所提供的检测中成药中掺杂化学药品的方法,还具有这样的特征:步骤三中,表面增强剂的滴加量为3μL~5μL,所采用的便携式拉曼光谱仪的激发波长为785nm。Furthermore, the method for detecting doped chemicals in Chinese patent medicines provided by the present invention also has the following characteristics: in step 3, the amount of the surface enhancer added is 3 μL to 5 μL, and the excitation of the portable Raman spectrometer used The wavelength is 785nm.
发明作用与效果Invention function and effect
本发明提供了一种检测中成药中掺杂化学药品的方法,采用表面增强拉曼光谱与薄层色谱法联用的技术进行检测,表面增强剂采用以甘油为溶剂的纳米金属溶胶。相对于现有技术选择水作为溶剂,甘油的粘度较大,使其挥发性更小,当甘油和金属纳米粒子混匀后,可以更长时间包裹在金属纳米粒子的外围,减少金属纳米粒子和外界接触而被氧化失效的机会,进而降低了金属纳米粒子的削减速度。一方面,提高了SERS信号的稳定性,信号可维持上百秒,实现对低含量掺伪中成药更好的现场快检;另一方面,提高了检测的灵敏度,如,当采用以水为溶剂的金属纳米粒子作为表面增强剂时,该方法检测中成药中的掺杂化学药品的质量分数的下限为0.1%,而当采用以甘油为溶剂的金属纳米粒子作为表面增强剂时,该方法检测中成药中的掺杂化学药品的质量分数的下限为0.01%,灵敏度提高了一个数量级。The invention provides a method for detecting doped chemicals in Chinese patent medicines, which adopts surface-enhanced Raman spectroscopy combined with thin-layer chromatography for detection, and uses glycerol as a solvent nanometer metal sol for the surface enhancer. Compared with the prior art, choosing water as a solvent, glycerol has a higher viscosity, which makes it less volatile. When glycerin and metal nanoparticles are mixed, they can be wrapped around the metal nanoparticles for a longer period of time, reducing metal nanoparticles and metal nanoparticles. The chance of being oxidized and invalidated by external contact reduces the reduction speed of metal nanoparticles. On the one hand, the stability of the SERS signal is improved, and the signal can be maintained for hundreds of seconds, enabling better on-site rapid detection of low-content adulterated Chinese patent medicines; on the other hand, the detection sensitivity is improved. For example, when using water as the When the metal nanoparticles of the solvent are used as the surface enhancer, the lower limit of the mass fraction of the doping chemicals in the Chinese patent medicine detected by this method is 0.1%, and when the metal nanoparticles with glycerin as the solvent are used as the surface enhancer, the method The lower limit for detecting the mass fraction of doping chemicals in Chinese patent medicines is 0.01%, and the sensitivity is improved by an order of magnitude.
附图说明Description of drawings
图1是本发明的检测中成药中掺杂化学药品方法的流程图;Fig. 1 is the flowchart of the method for doping chemicals in detection Chinese patent medicine of the present invention;
图2(a)是本发明实施例一中的标准品的动态表面增强拉曼光谱图;Fig. 2 (a) is the dynamic surface enhanced Raman spectrogram of the standard product in the embodiment of the present invention;
图2(b)是本发明实施例一中的掺杂化学药品的动态表面增强拉曼光谱图;Fig. 2 (b) is the dynamic surface-enhanced Raman spectrogram of the doping chemicals in the first embodiment of the present invention;
图3是本发明实施例一中的掺杂化学药品与其标准品的动态表面增强拉曼光谱对比图;Fig. 3 is a dynamic surface-enhanced Raman spectrum comparison diagram of doping chemicals and their standard products in Example 1 of the present invention;
图4(a)是本发明实施例二中的标准品的动态表面增强拉曼光谱图;Fig. 4 (a) is the dynamic surface-enhanced Raman spectrogram of the standard product in the second embodiment of the present invention;
图4(b)是本发明实施例二中的掺杂化学药品的动态表面增强拉曼光谱图;Fig. 4 (b) is the dynamic surface-enhanced Raman spectrogram of the doping chemicals in the second embodiment of the present invention;
图5是本发明实施例二中的掺杂化学药品与其标准品的动态表面增强拉曼光谱对比图;Fig. 5 is a dynamic surface-enhanced Raman spectrum comparison diagram of doping chemicals and their standard products in Example 2 of the present invention;
图6(a)是本发明实施例三中的标准品的动态表面增强拉曼光谱图;Fig. 6 (a) is the dynamic surface enhanced Raman spectrogram of the standard product in the embodiment three of the present invention;
图6(b)是本发明实施例三中的掺杂化学药品的动态表面增强拉曼光谱图;Fig. 6 (b) is the dynamic surface-enhanced Raman spectrogram of the doping chemicals in the third embodiment of the present invention;
图7是本发明实施例三中的掺杂化学药品与其标准品的动态表面增强拉曼光谱对比图。Fig. 7 is a comparison diagram of the dynamic surface-enhanced Raman spectra of the doping chemicals and their standard products in Example 3 of the present invention.
具体实施方式detailed description
以下结合附图来说明本发明的具体实施方式。The specific implementation manners of the present invention will be described below in conjunction with the accompanying drawings.
实施例一Embodiment one
本实施例以止咳平喘类中成药中常掺杂的盐酸苯海拉明的检测为例,对本发明的方法进行详细说明。In this embodiment, the method of the present invention is described in detail by taking the detection of diphenhydramine hydrochloride, which is often mixed in Chinese patent medicines for relieving cough and asthma, as an example.
一、仪器和样品1. Instruments and samples
仪器:便携式拉曼光谱仪(i-Raman;B&WTek;USA),激发波长785nm。Instrument: portable Raman spectrometer (i-Raman; B&WTek; USA), excitation wavelength 785nm.
银胶溶液的制备:称取90mg的硝酸银溶于500mL去离子水中加热至沸腾,加入10ml1%的柠檬酸钠,然后保持沸腾1h,冷却,得银胶溶液。Preparation of silver colloidal solution: Weigh 90 mg of silver nitrate, dissolve it in 500 mL of deionized water and heat to boiling, add 10 ml of 1% sodium citrate, keep boiling for 1 hour, cool to obtain silver colloidal solution.
掺杂化学药品的标准品溶液的制备:精密称定1.0mg的标准品,将标准品在1mL的甲醇中溶解、超声处理10~30min后,即得1mg/mL的标准品溶液。Preparation of standard solution doped with chemicals: Accurately weigh 1.0 mg of standard product, dissolve the standard product in 1 mL of methanol, and sonicate for 10-30 minutes to obtain a 1 mg/mL standard product solution.
待检药品溶液的制备:取一片中成药片剂,将该片剂研磨成细粉末后,在适量分析纯甲醇中溶解、超声处理10~30min后,离心取上清液,得到待检药品溶液。Preparation of the drug solution to be tested: Take a Chinese patent medicine tablet, grind the tablet into a fine powder, dissolve it in an appropriate amount of analytical pure methanol, and ultrasonically treat it for 10-30 minutes, then centrifuge to take the supernatant to obtain the drug solution to be tested .
其中,超声处理的时间优选20min。Wherein, the time of ultrasonic treatment is preferably 20min.
以上仪器以及样品的制备方法也适用于后续的实施例。The preparation methods of the above instruments and samples are also applicable to the following examples.
图1为本实施例中的检测中成药中掺杂化学药品方法的流程图。Fig. 1 is a flow chart of the method for detecting adulterated chemicals in Chinese patent medicines in this embodiment.
如图1所示,本实施例中检测止咳平喘类中成药中的盐酸苯海拉明的方法如下:As shown in Figure 1, the method for detecting diphenhydramine hydrochloride in the Chinese patent medicine for relieving cough and asthma in the present embodiment is as follows:
步骤1,制备甘油银胶溶液:取1mL甘油的体积分数为50%的甘油溶液与1mL银胶溶液混匀,得到甘油银胶;Step 1, preparing glycerin silver colloid solution: take 1 mL of glycerol solution with a volume fraction of 50% glycerol and mix with 1 mL silver colloid solution to obtain glycerin silver colloid;
步骤2,制备标准品溶液以及待检药品溶液:按上述方法制备;Step 2, prepare the standard solution and the drug solution to be tested: prepare according to the above method;
步骤3,薄板色谱层析分离:用毛细管分别吸取待检药品溶液和标准品溶液各1μL滴加于薄层板上,展开后在室温或加热温度下晾干;Step 3, thin-plate chromatography separation: absorb 1 μL each of the drug solution to be tested and the standard solution with a capillary tube, drop them on the thin-layer plate, and dry at room temperature or heating temperature after unfolding;
步骤4,采用波长为254nm的紫外灯进行斑点定位,确定待检药品中与标准品相对应的位置处是否存在斑点,若存在,将两个斑点记为待检位点进入步骤5,若不存在,重新选择标准品,进入步骤2;Step 4, use an ultraviolet lamp with a wavelength of 254nm for spot location, determine whether there are spots in the position corresponding to the standard product in the drug to be tested, if there are, record the two spots as the spots to be tested and enter step 5, if not exists, re-select the standard and go to step 2;
步骤5,在待检位点上滴加3μL甘油银胶溶液后利用便携式拉曼光谱仪进行动态检测,激光功率为200mw,积分时间为5s,动态采集时间为240s,分别得到各自的动态表面增强拉曼光谱图,如图2所示;Step 5, after dripping 3 μL glycerol silver colloid solution on the site to be tested, use a portable Raman spectrometer to perform dynamic detection. The laser power is 200mw, the integration time is 5s, and the dynamic acquisition time is 240s. Mann spectrogram, as shown in Figure 2;
步骤6,选取各自峰值最高的一张拉曼光谱进行对比,再通过谱段选取(550cm-1-1600cm-1)、基线校正(airPLS法)、平滑(Sgolay法)对这两个拉曼光谱进行预处理后,比较两图谱的差别,如图3所示。同时,结合待检位点在薄层板的比移值,确定中成药中是否添加了此类标准品。Step 6: Select a Raman spectrum with the highest peak value for comparison, and then compare the two Raman spectra through spectral segment selection (550cm -1 -1600cm -1 ), baseline correction (airPLS method), and smoothing (Sgolay method) After preprocessing, compare the difference between the two spectra, as shown in Figure 3. At the same time, combined with the ratio shift value of the site to be tested on the thin-layer plate, it was determined whether such a standard was added to the Chinese patent medicine.
图2(a)是本实施例中的标准品的动态表面增强拉曼光谱图。Figure 2(a) is the dynamic surface-enhanced Raman spectrum of the standard product in this example.
图2(b)是本实施例中的掺杂化学药品的动态表面增强拉曼光谱图。Figure 2(b) is a dynamic surface-enhanced Raman spectrum of the doping chemicals in this example.
如图2所示,标准品的动态表面增强拉曼光谱图中,第30s时拉曼光谱峰值强度最高;待检药品的动态表面增强拉曼光谱图中,第5s时的拉曼光谱峰值强度最高。As shown in Figure 2, in the dynamic surface-enhanced Raman spectrum of the standard product, the Raman spectrum peak intensity is the highest at the 30th second; in the dynamic surface-enhanced Raman spectrum of the drug to be tested, the Raman spectrum peak intensity at the 5th second Highest.
图3为本实施例一中的掺杂化学药品与其标准品的动态表面增强拉曼光谱对比图。FIG. 3 is a comparison diagram of the dynamic surface-enhanced Raman spectra of the doping chemicals and their standard products in the first embodiment.
如图3所示,标准品以及待检药品中谱峰值最强的两组拉曼光谱的峰型完全相同,由此可判定该中成药中添加有盐酸苯海拉明。As shown in Figure 3, the peak patterns of the Raman spectra of the two groups with the strongest spectral peaks in the standard substance and the drug to be tested are exactly the same, so it can be determined that diphenhydramine hydrochloride is added to the Chinese patent medicine.
实施例二:Embodiment two:
本实施例用于止咳平喘类中成药中常掺杂的磷酸苯丙哌林的检测,检测步骤如下:This embodiment is used for the detection of benproperine phosphate, which is often doped in Chinese patent medicines for relieving cough and asthma, and the detection steps are as follows:
步骤1,制备甘油银胶溶液:取1mL甘油的体积分数为50%的甘油溶液与1mL银胶溶液混匀,得到甘油银胶;Step 1, preparing glycerin silver colloid solution: take 1 mL of glycerol solution with a volume fraction of 50% glycerol and mix with 1 mL silver colloid solution to obtain glycerin silver colloid;
步骤2,制备标准品溶液以及待检药品溶液:按实施例一中的方法制备;Step 2, prepare the standard solution and the drug solution to be tested: prepare according to the method in Example 1;
步骤3,薄板色谱层析分离:用毛细管分别吸取待检药品溶液和标准品溶液各1μL滴加于薄层板上,展开后在室温或加热温度下晾干;Step 3, thin-plate chromatography separation: absorb 1 μL each of the drug solution to be tested and the standard solution with a capillary tube, drop them on the thin-layer plate, and dry at room temperature or heating temperature after unfolding;
步骤4,采用波长为254nm的紫外灯进行斑点定位,确定待检药品中与标准品相对应的位置处是否存在斑点,若存在,将两个斑点记为待检位点进入步骤5,若不存在,重新选择标准品,进入步骤2;Step 4, use an ultraviolet lamp with a wavelength of 254nm for spot location, determine whether there are spots in the position corresponding to the standard product in the drug to be tested, if there are, record the two spots as the spots to be tested and enter step 5, if not exists, re-select the standard and go to step 2;
步骤5,在待检位点上滴加4μL甘油银胶溶液后利用便携式拉曼光谱仪进行动态检测,激光功率为150mw,积分时间为5s,动态采集时间为240s,分别得到各自的动态表面增强拉曼光谱图,如图4所示;Step 5, after dripping 4 μL glycerol silver colloid solution on the site to be tested, use a portable Raman spectrometer to perform dynamic detection. The laser power is 150mw, the integration time is 5s, and the dynamic acquisition time is 240s. Mann spectrogram, as shown in Figure 4;
步骤6,选取各自峰值最高的一张拉曼光谱进行对比,再通过谱段选取(550cm-1-1600cm-1)、基线校正(airPLS法)、平滑(Sgolay法)对这两个拉曼光谱进行预处理后,比较两图谱的差别,如图5所示。同时,结合待检位点在薄层板的比移值,确定中成药中是否添加了此类标准品。Step 6: Select a Raman spectrum with the highest peak value for comparison, and then compare the two Raman spectra through spectral segment selection (550cm -1 -1600cm -1 ), baseline correction (airPLS method), and smoothing (Sgolay method) After preprocessing, compare the difference between the two spectra, as shown in Figure 5. At the same time, combined with the ratio shift value of the site to be tested on the thin-layer plate, it was determined whether such a standard was added to the Chinese patent medicine.
图4(a)是本实施例中的磷酸苯丙哌林标准品的动态表面增强拉曼光谱图。Fig. 4 (a) is the dynamic surface-enhanced Raman spectrum of the benproperine phosphate standard substance in this example.
图4(b)是本实施例中的掺杂化学药品的动态表面增强拉曼光谱图。Figure 4(b) is a dynamic surface-enhanced Raman spectrum of the doping chemicals in this example.
如图4所示,磷酸苯丙哌林标准品的动态表面增强拉曼光谱图中,第55s时的拉曼光谱峰值强度最高;待检药品的动态表面增强拉曼光谱图中,第30s时的拉曼光谱峰值强度最高。As shown in Figure 4, in the dynamic surface-enhanced Raman spectrum of the benproperine phosphate standard substance, the Raman spectrum peak intensity at the 55th s is the highest; in the dynamic surface-enhanced Raman spectrum of the drug to be tested, at the 30th s The peak intensity of the Raman spectrum is the highest.
图5为本实施例二中的掺杂化学药品与其标准品的动态表面增强拉曼光谱对比图。FIG. 5 is a comparison diagram of the dynamic surface-enhanced Raman spectra of the doping chemicals and their standard products in the second embodiment.
如图5所示,磷酸苯丙哌林标准品以及待检药品中掺杂的化学药品中谱峰值最强的两组拉曼光谱的峰型相同,由此可判定该中成药中添加有磷酸苯丙哌林。As shown in Figure 5, the Raman spectra of the two groups with the strongest spectral peaks in the standard benproperine phosphate and the chemical doped in the drug to be tested have the same peak shape, so it can be determined that phosphoric acid is added to the Chinese patent medicine phenproperine.
实施例三:Embodiment three:
本实施例用于止咳平喘类中成药中常掺杂的马来酸氯苯那敏的检测,检测步骤如下:This embodiment is used for the detection of chlorpheniramine maleate, which is often doped in Chinese patent medicines for relieving cough and asthma, and the detection steps are as follows:
步骤1,制备甘油银胶溶液:取1mL甘油的体积分数为50%的甘油溶液与1mL银胶溶液混匀,得到甘油银胶;Step 1, preparing glycerin silver colloid solution: take 1 mL of glycerol solution with a volume fraction of 50% glycerol and mix with 1 mL silver colloid solution to obtain glycerin silver colloid;
步骤2,制备标准品溶液以及待检药品溶液:按实施例一中的方法制备;Step 2, prepare the standard solution and the drug solution to be tested: prepare according to the method in Example 1;
步骤3,薄板色谱层析分离:用毛细管分别吸取待检药品溶液和标准品溶液各1μL滴加于薄层板上,展开后在室温或加热温度下晾干;Step 3, thin-plate chromatography separation: absorb 1 μL each of the drug solution to be tested and the standard solution with a capillary tube, drop them on the thin-layer plate, and dry at room temperature or heating temperature after unfolding;
步骤4,采用波长为254nm的紫外灯进行斑点定位,确定待检药品中与标准品相对应的位置处是否存在斑点,若存在,将两个斑点记为待检位点进入步骤5,若不存在,重新选择标准品,进入步骤2;Step 4, use an ultraviolet lamp with a wavelength of 254nm for spot location, determine whether there are spots in the position corresponding to the standard product in the drug to be tested, if there are, record the two spots as the spots to be tested and enter step 5, if not exists, re-select the standard and go to step 2;
步骤5,在待检位点上滴加5μL甘油银胶溶液后利用便携式拉曼光谱仪进行动态检测,激光功率为300mw,积分时间为5s,动态采集时间为240s,分别得到各自的动态表面增强拉曼光谱图,如图6所示;Step 5, after dripping 5 μL glycerol silver colloid solution on the site to be tested, use a portable Raman spectrometer to perform dynamic detection. The laser power is 300mw, the integration time is 5s, and the dynamic acquisition time is 240s. Mann spectrogram, as shown in Figure 6;
步骤6,选取各自峰值最高的一张拉曼光谱进行对比,再通过谱段选取(550cm-1-1600cm-1)、基线校正(airPLS法)、平滑(Sgolay法)对这两个拉曼光谱进行预处理后,比较两图谱的差别,如图7所示。同时,结合待检位点在薄层板的比移值,确定中成药中是否添加了此类化学药品。Step 6: Select a Raman spectrum with the highest peak value for comparison, and then compare the two Raman spectra through spectral segment selection (550cm -1 -1600cm -1 ), baseline correction (airPLS method), and smoothing (Sgolay method) After preprocessing, compare the difference between the two spectra, as shown in Figure 7. At the same time, combined with the ratio shift value of the site to be tested on the thin-layer plate, it is determined whether such chemicals are added to the Chinese patent medicine.
图6(a)是本实施例中的马来酸氯苯那敏标准品的动态表面增强拉曼光谱图。Fig. 6 (a) is the dynamic surface enhanced Raman spectrogram of the chlorpheniramine maleate standard substance in the present embodiment.
图6(b)是本实施例中的掺杂化学药品的动态表面增强拉曼光谱图。Figure 6(b) is a dynamic surface-enhanced Raman spectrum of the doping chemicals in this example.
如图6所示,马来酸氯苯那敏标准品的动态表面增强拉曼光谱图中,第105s时的拉曼光谱峰值强度最高;待检药品的动态表面增强拉曼光谱图中,第30s时的拉曼光谱峰值强度最高。As shown in Figure 6, in the dynamic surface-enhanced Raman spectrum of chlorpheniramine maleate standard substance, the Raman spectrum peak intensity at the 105th s is the highest; in the dynamic surface-enhanced Raman spectrum of the drug to be tested, the first The peak intensity of the Raman spectrum is the highest at 30s.
图7为本实施例三中的掺杂化学药品与其标准品的动态表面增强拉曼光谱对比图。FIG. 7 is a comparison diagram of the dynamic surface-enhanced Raman spectra of the doping chemicals and their standard products in the third embodiment.
如图7所示,马来酸氯苯那敏标准品以及待检药品中掺杂的化学药品中谱峰值最强的两组拉曼光谱的峰型相同,由此可判定该中成药中添加有马来酸氯苯那敏。As shown in Figure 7, the Raman spectra of the two groups with the strongest spectrum peaks in the standard chlorpheniramine maleate and the chemical doped in the drug to be tested have the same peak shape, so it can be determined that the additive in the Chinese patent medicine There is chlorpheniramine maleate.
以上三个实施例中,每次只选择一个标准品和待检中成药的样品进行对照检测。而实际上,一种中成药中或许掺杂有多种化学药品,在利用本实施例的方法进行中成药中掺杂有化学药品的成分检测之前,可以先通过其他方法粗略判断可能掺杂的化药成分,然后配置这些成分的标准品溶液以及待检中成药的溶液,将其同时在薄层板上点样,而后进行动态拉曼光谱的采集。In the above three embodiments, only one standard product and a sample of the Chinese patent medicine to be tested are selected for control detection each time. In fact, a kind of Chinese patent medicine may be mixed with many kinds of chemicals. Before using the method of this embodiment to detect the ingredients mixed with chemicals in Chinese patent medicine, other methods can be used to roughly judge the possible doped ingredients. Chemical components, and then configure the standard solution of these components and the solution of the Chinese patent medicine to be tested, and spot them on the thin-layer plate at the same time, and then collect the dynamic Raman spectrum.
以上三个实施例中,为了取得更好的检测效果,采用便携式拉曼光谱仪对待检位点进行动态检测的时间均为240s,但实际使用时,可根据实际情况灵活进行调整,但最好不要低于60s,以免获得的图谱过少,难以选择强度最大的图谱,导致后面的比较出现较大误差。In the above three embodiments, in order to obtain better detection results, the dynamic detection time of the site to be detected by the portable Raman spectrometer is 240s, but in actual use, it can be flexibly adjusted according to the actual situation, but it is best not to It is lower than 60s, so as not to obtain too few spectra, it is difficult to select the spectrum with the highest intensity, resulting in a large error in the subsequent comparison.
以上三个实施例中,利用便携式拉曼光谱仪进行动态检测时,所采用的积分时间为5s。实际上还可以采用5s~10s范围内的任意一个数值作为积分时间,只要能够满足后面的分析需求即可。In the above three embodiments, when a portable Raman spectrometer is used for dynamic detection, the integration time used is 5s. In fact, any value within the range of 5s to 10s can be used as the integration time, as long as it can meet the analysis requirements later.
实施例作用与效果Function and effect of embodiment
本实施例提供了一种检测中成药中掺杂化学药品的方法,采用表面增强拉曼光谱与薄层色谱法联用的技术进行检测,表面增强剂采用以甘油为溶剂的纳米金属溶胶。相对于现有技术选择水作为溶剂,甘油的粘度较大,使其挥发性更小,当甘油和金属纳米粒子混匀后,可以更长时间包裹在金属纳米粒子的外围,减少金属纳米粒子和外界接触而被氧化失效的机会,进而降低了金属纳米粒子的削减速度。一方面,提高了SERS信号的稳定性,信号可维持上百秒,实现对低含量掺伪中成药更好的现场快检;另一方面,提高了检测的灵敏度,如,当采用以水为溶剂的金属纳米粒子作为表面增强剂时,该方法检测中成药中的掺杂化学药品的质量分数的下限为0.1%,而当采用以甘油为溶剂的金属纳米粒子作为表面增强剂时,该方法检测中成药中的掺杂化学药品的质量分数的下限为0.01%,灵敏度提高了一个数量级。This example provides a method for detecting doped chemicals in Chinese patent medicines, using surface-enhanced Raman spectroscopy combined with thin-layer chromatography for detection, and using nano-metal sol with glycerol as a solvent for the surface enhancer. Compared with the prior art, choosing water as a solvent, glycerol has a higher viscosity, which makes it less volatile. When glycerin and metal nanoparticles are mixed, they can be wrapped around the metal nanoparticles for a longer period of time, reducing metal nanoparticles and metal nanoparticles. The chance of being oxidized and invalidated by external contact reduces the reduction speed of metal nanoparticles. On the one hand, the stability of the SERS signal is improved, and the signal can be maintained for hundreds of seconds, enabling better on-site rapid detection of low-content adulterated Chinese patent medicines; on the other hand, the detection sensitivity is improved. For example, when using water as the When the metal nanoparticles of the solvent are used as the surface enhancer, the lower limit of the mass fraction of the doping chemicals in the Chinese patent medicine detected by this method is 0.1%, and when the metal nanoparticles with glycerin as the solvent are used as the surface enhancer, the method The lower limit for detecting the mass fraction of doping chemicals in Chinese patent medicines is 0.01%, and the sensitivity is improved by an order of magnitude.
以上实施例中,以检测止咳平喘类中成药中掺杂的化学药品为例对本发明的方法进行说明。但本发明的方法同样适用于其他类型的中成药中掺杂化学药品的检测,此时,样品制备、层析以及动态拉曼光谱的选择三个步骤的方法应根据待检药品的实际情况而进行相应改变。In the above embodiments, the method of the present invention is described by taking the detection of chemicals doped in Chinese patent medicines for relieving cough and asthma as an example. However, the method of the present invention is equally applicable to the detection of doped chemicals in other types of Chinese patent medicines. At this time, the method of the three steps of sample preparation, chromatography and dynamic Raman spectrum selection should be determined according to the actual situation of the drug to be tested. Make the appropriate changes.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510551339.5A CN105223182A (en) | 2015-09-01 | 2015-09-01 | A kind of method detecting doped chemical drugs in Chinese patent drug |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510551339.5A CN105223182A (en) | 2015-09-01 | 2015-09-01 | A kind of method detecting doped chemical drugs in Chinese patent drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105223182A true CN105223182A (en) | 2016-01-06 |
Family
ID=54992256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510551339.5A Pending CN105223182A (en) | 2015-09-01 | 2015-09-01 | A kind of method detecting doped chemical drugs in Chinese patent drug |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105223182A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106526060A (en) * | 2016-09-21 | 2017-03-22 | 中国人民解放军第二军医大学 | eTLC-SERS method |
| CN107064401A (en) * | 2016-09-30 | 2017-08-18 | 中国人民解放军第二军医大学 | A kind of quick method for detecting ten kinds of pigments of illegal addition in beverage simultaneously |
| CN107505305A (en) * | 2017-07-26 | 2017-12-22 | 中国人民解放军第二军医大学 | A kind of method of illegal addition silaenafil analog in quick analysis Yang-establishing health product |
| CN109613167A (en) * | 2018-12-17 | 2019-04-12 | 江南大学 | A method for screening riboflavin in food and drug by combining high performance thin layer chromatography and surface enhanced Raman spectroscopy |
| CN110333214A (en) * | 2018-11-14 | 2019-10-15 | 厦门市普识纳米科技有限公司 | The detection method of illegal addition drug ingredient in a kind of health care product |
| CN111060645A (en) * | 2019-12-25 | 2020-04-24 | 安徽中科赛飞尔科技有限公司 | SERS detection method for adulterated drugs |
| CN115808411A (en) * | 2022-11-09 | 2023-03-17 | 西南交通大学 | Glycerin liquid film SERS substrate and its preparation method and application |
| CN116297389A (en) * | 2023-02-15 | 2023-06-23 | 中国人民解放军空军特色医学中心 | Drug detection method capable of causing driving operation disability in biological sample at accident site |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103115912A (en) * | 2013-01-23 | 2013-05-22 | 中国科学院合肥物质科学研究院 | Surface enhanced raman spectrum printing test paper for field test and preparation method thereof |
| US20130128265A1 (en) * | 2011-11-07 | 2013-05-23 | University Of Georgia Research Foundation, Inc. | Thin layer chromatography-surfaced enhanced raman spectroscopy chips and methods of use |
| CN103954608A (en) * | 2014-05-20 | 2014-07-30 | 中国人民解放军第二军医大学 | Method for identifying whether blood-glucose-lowering traditional Chinese medicine contains pioglitazone or rosiglitazone or not |
| CN104833669A (en) * | 2015-04-29 | 2015-08-12 | 中国人民解放军第二军医大学 | Rapid detection method of drugs with weak main drug signal |
-
2015
- 2015-09-01 CN CN201510551339.5A patent/CN105223182A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130128265A1 (en) * | 2011-11-07 | 2013-05-23 | University Of Georgia Research Foundation, Inc. | Thin layer chromatography-surfaced enhanced raman spectroscopy chips and methods of use |
| CN103115912A (en) * | 2013-01-23 | 2013-05-22 | 中国科学院合肥物质科学研究院 | Surface enhanced raman spectrum printing test paper for field test and preparation method thereof |
| CN103954608A (en) * | 2014-05-20 | 2014-07-30 | 中国人民解放军第二军医大学 | Method for identifying whether blood-glucose-lowering traditional Chinese medicine contains pioglitazone or rosiglitazone or not |
| CN104833669A (en) * | 2015-04-29 | 2015-08-12 | 中国人民解放军第二军医大学 | Rapid detection method of drugs with weak main drug signal |
Non-Patent Citations (4)
| Title |
|---|
| DENNIS STEINIGEWEG 等: "Monodispersity and size control in the synthesis of 20–100 nm quasi-spherical silver nanoparticles by citrate and ascorbic acid reduction in glycerol–water mixtures", 《CHEM. COMMUN.》 * |
| MONICA POTARA 等: "Solution-phase, dual LSPR-SERS plasmonic sensors of high sensitivity and stability based on chitosan-coated anisotropic silver nanoparticles", 《JOURNAL OF MATERIALS CHEMISTRY》 * |
| 朱青霞: "TLC-SERS用于中药掺杂化学成分的检测方法研究", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 * |
| 秦剑红: "TLC-SERS联用法检测降糖中成药中添加的格列类药品", 《药学实践杂志》 * |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106526060A (en) * | 2016-09-21 | 2017-03-22 | 中国人民解放军第二军医大学 | eTLC-SERS method |
| CN106526060B (en) * | 2016-09-21 | 2018-05-29 | 中国人民解放军第二军医大学 | A kind of eTLC-SERS methods |
| CN107064401A (en) * | 2016-09-30 | 2017-08-18 | 中国人民解放军第二军医大学 | A kind of quick method for detecting ten kinds of pigments of illegal addition in beverage simultaneously |
| CN107505305A (en) * | 2017-07-26 | 2017-12-22 | 中国人民解放军第二军医大学 | A kind of method of illegal addition silaenafil analog in quick analysis Yang-establishing health product |
| CN107505305B (en) * | 2017-07-26 | 2020-09-04 | 中国人民解放军第二军医大学 | Method for rapidly analyzing illegal addition of sildenafil analogue in yang-strengthening health-care product |
| CN110333214A (en) * | 2018-11-14 | 2019-10-15 | 厦门市普识纳米科技有限公司 | The detection method of illegal addition drug ingredient in a kind of health care product |
| CN109613167A (en) * | 2018-12-17 | 2019-04-12 | 江南大学 | A method for screening riboflavin in food and drug by combining high performance thin layer chromatography and surface enhanced Raman spectroscopy |
| WO2020125532A1 (en) * | 2018-12-17 | 2020-06-25 | 江南大学 | Method for screening riboflavin in food and drugs by means of combined use of high-performance thin-layer chromatography and surface-enhanced raman spectroscopy |
| CN111060645A (en) * | 2019-12-25 | 2020-04-24 | 安徽中科赛飞尔科技有限公司 | SERS detection method for adulterated drugs |
| CN115808411A (en) * | 2022-11-09 | 2023-03-17 | 西南交通大学 | Glycerin liquid film SERS substrate and its preparation method and application |
| CN116297389A (en) * | 2023-02-15 | 2023-06-23 | 中国人民解放军空军特色医学中心 | Drug detection method capable of causing driving operation disability in biological sample at accident site |
| CN116297389B (en) * | 2023-02-15 | 2023-12-26 | 中国人民解放军空军特色医学中心 | Drug detection method capable of causing driving operation disability in biological sample at accident site |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105223182A (en) | A kind of method detecting doped chemical drugs in Chinese patent drug | |
| CN103217393B (en) | Detection method for adulterated tea oil | |
| CN103954608B (en) | A kind of identify the method whether adding pioglitazone or rosiglitazone in blood-sugar lowering tcm drug | |
| CN105241861B (en) | It is a kind of quickly to detect ten kinds of methods for mixing pseudo- component in lipid-loweringing class Chinese patent drug at the same time | |
| CN103968946B (en) | A collection method of surface-enhanced Raman two-dimensional correlation spectrum | |
| Attia et al. | Spectrofluorimetric assessment of metoclopramide hydrochloride using terbium doped in PMMA matrix optical sensor | |
| Hu et al. | Rapid detection of six phosphodiesterase type 5 enzyme inhibitors in healthcare products using thin‐layer chromatography and surface enhanced Raman spectroscopy combined with BP neural network | |
| Fan et al. | Si@ Ag@ PEI substrate-based SERS sensor for rapid detection of illegally adulterated sulfur dioxide in traditional Chinese medicine | |
| Yang et al. | Evaluating the quality consistency of Keteling capsules by three-dimensional quantum fingerprints and HPLC fingerprint | |
| Attia et al. | Nalbuphine HCl assessment by the quenching of the emission of Tb-4’Carboxybenzo-18crown-6-Ether optical sensor | |
| CN109765322A (en) | The characteristic spectrum construction method and quality determining method of schizonepeta | |
| Erdogan et al. | A novel spectrophotometric method based on plasmonic nanoparticles for nicotine detection | |
| Attia et al. | Highly sensitive and selective spectrofluorimetric determination of metoclopramide hydrochloride in pharmaceutical tablets and serum samples using Eu3+ ion doped in sol–gel matrix | |
| CN104330482A (en) | Method utilizing HPLC to simultaneously measure 17 characteristic components in tea | |
| CN104833669B (en) | A kind of quick determination method of weak main ingredient signal medicine | |
| CN114216980B (en) | Method for establishing HPLC-ELSD fingerprint of starwort root | |
| Hu et al. | SPE‐UHPLC‐FLD method for the simultaneous determination of five anthraquinones in human urine using mixed‐mode bis (tetraoxacalix [2] arene [2] triazine) modified silica as sorbent | |
| CN107727640A (en) | A kind of method for differentiating essence spice for cigarette using SERS method | |
| CN102175629A (en) | Biological activity detection-based evaluation method of quality of prepared radix rehmanniae | |
| CN104807804B (en) | A kind of quick determination method of weak main ingredient signal medicine | |
| Xu et al. | Rapid construction of interfacial plasmonic nanoarray for SERS sensing of flavonoids | |
| CN108037234B (en) | Quality detection method of abrus herb hepatitis granules | |
| CN110408397A (en) | A kind of preparation method of CeCl3:Eu3+ fluorescent probe array | |
| CN103743716B (en) | The detection method of Ligusticum chuanxiong Hort, authentication method | |
| CN104777244A (en) | Quality detection method for qi-moving Tannikaer capsule |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160106 |
|
| RJ01 | Rejection of invention patent application after publication |